Cystine stones

Nephrology

Volumn 12, Issue SUPPL. 1, 2007, Pages

  Becker, Gavin ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CAPTOPRIL; CITRATE POTASSIUM; CYSTINE; PENICILLAMINE; POTASSIUM BICARBONATE; THIOL DERIVATIVE; TIOPRONIN;

ABDOMINAL PAIN; AGEUSIA; ANEMIA; ANOREXIA; ARTHRALGIA; CHROMOSOME 9; COCHRANE LIBRARY; CYSTINURIA; DIARRHEA; DRUG WITHDRAWAL; EDEMA; GENE MUTATION; HUMAN; LUPUS LIKE SYNDROME; MALAISE; NAUSEA; NEPHROLITHIASIS; NEPHROTIC SYNDROME; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; RASH; REVIEW; STONE ANALYSIS; THROMBOCYTOPENIA; URINE PH; VOMITING; WATER TREATMENT; CHEMISTRY; PRACTICE GUIDELINE;

CYSTINE; HUMANS; KIDNEY CALCULI;

EID: 33847003312     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00722.x     Document Type: Review

References (27)

1. Smith A, Yu JS, Brown DA. Childhood cystinuria in New South Wales. Results in children who were followed up after being detected by urinary screening in infancy. Arch. Dis. Child. 1979; 54: 676-81.
2. Smith A, Wilcken B. Homozygous cystinuria in New South Wales. A study of 110 individuals with cystinuria ascertained by methods other than neonatal screening. Med. J. Aust. 1984; 141: 500-2.
3. Turner B, Brown DA. Amino acid excretion in infancy and early childhood. A survey of 200 000 infants. Med. J. Aust. 1972; 1: 62-5.
4. Nakagawa Y, Coe FL. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin. Chim. Acta 1999; 289: 57-68.
5. Finocchiaro R, D'Eufemia P, Celli M et al. Usefulness of cyanidenitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: A standardized dilution procedure. Urol. Res. 1998; 26: 401-5.
6. Fekkes D. State-of-the-art of high-performance liquid chromatographic analysis of amino acids in physiological samples. J. Chromatogr. B Biomed. Appl. 1996; 682: 3-22.
7. Campanella L, Crescentini G, Avino P. Simultaneous determination of cysteine, cystine and 18 other amino acids in various matrices by high-performance liquid chromatography. J. Chromatogr. 1999; 833: 137-45.
8. Lindell A, Denneberg T, Edholm E et al. The effect of sodium intake on cystinuria with and without tiopronin treatment. Nephron 1995; 71: 407-15.
9. Pras E, Sood R, Raben N et al. Genomic organization of SLC3A1, a transporter gene mutated in cystinuria. Genomics 1996; 36: 163-7.
10. Saadi I, Chen XZ, Hediger M et al. Molecular genetics of cystinuria: Mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype. Kidney Int. 1998; 54: 48-55.
11. Goodyer P, Saadi I, Ong P et al. Cystinuria subtyre and risk of nephrolithiasis. Kidney Int. 1998; 54: 56-61.
12. Lahme S, Bichler KH, Eggermann T et al. Genomic and functional investigations of mutations of the SLC3A1 gene in cystinuria. Urol. Int. 2002; 69: 207-11.
13. Chesney RW. Mutational analysis of patients with cystinuria detected by a genetic screening network: Powerful tools in understanding the several forms of the disorder. Kidney Int. 1998; 54: 279-80.
14. Dent CE, Senior B. Studies on the treatment of cystinuria. Br. J. Urol. 1955; 27: 317-32.
15. Ettinger B, Kolb FO. Factors involved in crystal formation in cystinuria. In vivo and in vitro crystallization dynamics and a simple, quantitative colorimetic assay for cystine. J. Urol. 1971; 106: 106-10.
16. Dent CE, Friedman M, Green H et al. Treatment of cystinuria. Br. Med. J. 1965; 1: 403-8.
17. Singer A, Das S. Cystinuria: A review of the pathophysiology and management. J. Urol. 1989; 142: 669-73.
18. Fjellstedt E, Denneberg T, Jeppsson JO et al. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol. Res. 2001; 29: 295-302.
19. Halperin EC, Thier SO, Rosenberg LE. The use of D-penicillamine in cystinuria: Efficacy and untoward reactions. Yale J. Biol. Med. 1981; 54: 439-46.
20. Miano L, Gallucci M, Petta S. Results of medical treatment of cystine lithiasis. Eur. Urol. 1979; 5: 265-72.
21. Koide T, Kinoshita K, Takemoto M et al. Conservative treatment of cystine calculi: Effect of oral alpha-mercaptopropionylglycine on cystine stone dissolution and on prevention of stone recurrence. J. Urol. 1982; 128: 513-16.
22. Pak CY, Fuller C, Sakhaee K et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J. Urol. 1986; 136: 1003-8.
23. Linari F, Malfi B, Bajardi P et al. Aminoacidemia and aminoaciduria in primary and secondary cystinuria. Minerva Urol. 1981; 33: 1-4.
24. Sloand JA, Izzo JL Jr. Captopril reduces urinary cystine excretion in cystinuria. Arch. Intern. Med. 1987; 147: 1409-12.
25. Cohen TD, Streem SB, Hall P. Clinical effect of captopril on the formation and growth of cystine calculi. J. Urol. 1995; 154: 164-6.
26. Barbey F, Joly D, Rieu P et al. Medical treatment of cystinuria: Critical reappraisal of long-term results. J. Urol. 2000; 163: 1419-23.
27. Chow GK, Streem SB. Medical treatment of cystinuria: Results of contemporary clinical practice. J. Urol. 1996; 156: 1576-8.